{"id":"https://openalex.org/W2006673542","doi":"https://doi.org/10.1177/0091270008329556","title":"Population Pharmacokinetic Modeling of Ustekinumab, a Human Monoclonal Antibody Targeting IL\u201012/23p40, in Patients With Moderate to Severe Plaque Psoriasis","display_name":"Population Pharmacokinetic Modeling of Ustekinumab, a Human Monoclonal Antibody Targeting IL\u201012/23p40, in Patients With Moderate to Severe Plaque Psoriasis","alternate_titles":[],"publication_year":2009,"publication_date":"2009-01-28","ids":{"openalex":"https://openalex.org/W2006673542","doi":"https://doi.org/10.1177/0091270008329556","mag":"2006673542","pmid":"https://pubmed.ncbi.nlm.nih.gov/19179295"},"language":"en","primary_location":{"id":"doi:10.1177/0091270008329556","doi":"https://doi.org/10.1177/0091270008329556","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0091270008329556","pdf_url":null,"source":{"id":"https://openalex.org/S146237847","display_name":"The Journal of Clinical Pharmacology","issn_l":"0021-9754","issn":["0021-9754","0091-2700","0095-9863","1552-4604","2375-0839","2375-0928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2006673542"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012645652","display_name":"Yaowei Zhu","orcid":"https://orcid.org/0000-0002-3464-5785","observed_orcids":["https://orcid.org/0000-0002-3464-5785"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yaowei Zhu","raw_affiliation_strings":["Pharmacokinetics, Modeling & Simulation, Clinical Pharmacology Sciences, Centocor Research & Development, Inc, 200 Great Valley Parkway, Malvern, PA 19355, USA","Centocor Research and Development, Inc, Malvern, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacokinetics, Modeling & Simulation, Clinical Pharmacology Sciences, Centocor Research & Development, Inc, 200 Great Valley Parkway, Malvern, PA 19355, USA","institution_ids":[]},{"raw_affiliation_string":"Centocor Research and Development, Inc, Malvern, Pennsylvania","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045240294","display_name":"Chuanpu Hu","orcid":"https://orcid.org/0000-0001-7812-2778","observed_orcids":["https://orcid.org/0000-0001-7812-2778"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chuanpu Hu","raw_affiliation_strings":["Centocor Research and Development, Inc, Malvern, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centocor Research and Development, Inc, Malvern, Pennsylvania","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102741714","display_name":"Ming Lu","orcid":"https://orcid.org/0000-0002-7946-9797","observed_orcids":["https://orcid.org/0000-0002-7946-9797","https://orcid.org/0009-0001-7307-3863"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ming Lu","raw_affiliation_strings":["Centocor Research and Development, Inc, Malvern, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centocor Research and Development, Inc, Malvern, Pennsylvania","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054149626","display_name":"Sam Liao","orcid":"https://orcid.org/0000-0002-2710-7890","observed_orcids":["https://orcid.org/0000-0002-2710-7890"]},"institutions":[{"id":"https://openalex.org/I66951643","display_name":"Pillar College","ror":"https://ror.org/02q3cpg22","country_code":"US","type":"education","lineage":["https://openalex.org/I66951643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sam Liao","raw_affiliation_strings":["PharMax Research, Inc, Somerset, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PharMax Research, Inc, Somerset, New Jersey","institution_ids":["https://openalex.org/I66951643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027075504","display_name":"Joseph C. Marini","orcid":"https://orcid.org/0000-0002-2827-0729","observed_orcids":["https://orcid.org/0000-0002-2827-0729"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph C. Marini","raw_affiliation_strings":["Centocor Research and Development, Inc, Malvern, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centocor Research and Development, Inc, Malvern, Pennsylvania","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000938395","display_name":"Jennifer Yohrling","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer Yohrling","raw_affiliation_strings":["Centocor Research and Development, Inc, Malvern, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centocor Research and Development, Inc, Malvern, Pennsylvania","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071777072","display_name":"Newman M. Yeilding","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Newman Yeilding","raw_affiliation_strings":["Centocor Research and Development, Inc, Malvern, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centocor Research and Development, Inc, Malvern, Pennsylvania","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076610847","display_name":"Hugh M. Davis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hugh M. Davis","raw_affiliation_strings":["Centocor Research and Development, Inc, Malvern, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centocor Research and Development, Inc, Malvern, Pennsylvania","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031629161","display_name":"Honghui Zhou","orcid":"https://orcid.org/0000-0002-5149-1458","observed_orcids":["https://orcid.org/0000-0002-5149-1458"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Honghui Zhou","raw_affiliation_strings":["Centocor Research and Development, Inc, Malvern, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centocor Research and Development, Inc, Malvern, Pennsylvania","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5031629161"],"corresponding_institution_ids":[],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":5.3744,"has_fulltext":false,"cited_by_count":176,"citation_normalized_percentile":{"value":0.96283831,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"49","issue":"2","first_page":"162","last_page":"175"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9063000082969666,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9063000082969666,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.04399999976158142,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.006800000090152025,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ustekinumab","display_name":"ustekinumab","score":1.0},{"id":"https://openalex.org/keywords/population-pharmacokinetics","display_name":"population pharmacokinetics","score":0.9229999780654907},{"id":"https://openalex.org/keywords/plaque-psoriasis","display_name":"plaque psoriasis","score":0.984000027179718},{"id":"https://openalex.org/keywords/il-12-23p40","display_name":"IL-12/23p40","score":0.8370000123977661},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9369999766349792},{"id":"https://openalex.org/keywords/apparent-clearance","display_name":"apparent clearance","score":0.6439999938011169},{"id":"https://openalex.org/keywords/volume-of-distribution","display_name":"volume of distribution","score":0.9549999833106995},{"id":"https://openalex.org/keywords/inter-individual-variability","display_name":"interindividual variability","score":0.9240000247955322},{"id":"https://openalex.org/keywords/covariates","display_name":"covariates","score":0.8119999766349792},{"id":"https://openalex.org/keywords/body-weight","display_name":"body weight","score":0.9210000038146973},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.9639999866485596},{"id":"https://openalex.org/keywords/anti-drug-antibodies","display_name":"anti-drug antibodies","score":0.9039999842643738}],"concepts":[{"id":"https://openalex.org/C2778975655","wikidata":"https://www.wikidata.org/wiki/Q420305","display_name":"Ustekinumab","level":4,"score":0.9054299592971802},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8053263425827026},{"id":"https://openalex.org/C139254425","wikidata":"https://www.wikidata.org/wiki/Q1332167","display_name":"Volume of distribution","level":3,"score":0.6361334919929504},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6151391267776489},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.6024488210678101},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.5433202385902405},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47537127137184143},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.389814168214798},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3025369644165039},{"id":"https://openalex.org/C2780132546","wikidata":"https://www.wikidata.org/wiki/Q348260","display_name":"Adalimumab","level":3,"score":0.08040699362754822},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.05603441596031189},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069549","descriptor_name":"Ustekinumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003920","descriptor_name":"Diabetes Mellitus","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017326","descriptor_name":"Clinical Trials, Phase III as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018664","descriptor_name":"Interleukin-12","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D053759","descriptor_name":"Interleukin-23","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/0091270008329556","doi":"https://doi.org/10.1177/0091270008329556","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0091270008329556","pdf_url":null,"source":{"id":"https://openalex.org/S146237847","display_name":"The Journal of Clinical Pharmacology","issn_l":"0021-9754","issn":["0021-9754","0091-2700","0095-9863","1552-4604","2375-0839","2375-0928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:19179295","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19179295","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W1606914758","https://openalex.org/W1919174115","https://openalex.org/W1968690857","https://openalex.org/W1985320060","https://openalex.org/W1986040556","https://openalex.org/W2006249161","https://openalex.org/W2008223306","https://openalex.org/W2009219530","https://openalex.org/W2013488106","https://openalex.org/W2032582147","https://openalex.org/W2035502939","https://openalex.org/W2039144093","https://openalex.org/W2041817016","https://openalex.org/W2046909730","https://openalex.org/W2059028786","https://openalex.org/W2062826169","https://openalex.org/W2063194385","https://openalex.org/W2066865216","https://openalex.org/W2071343804","https://openalex.org/W2072683923","https://openalex.org/W2073058693","https://openalex.org/W2078562507","https://openalex.org/W2109506765","https://openalex.org/W2116400276","https://openalex.org/W2116956799","https://openalex.org/W2126162679","https://openalex.org/W2151566115","https://openalex.org/W2152232379","https://openalex.org/W2160242026","https://openalex.org/W2161446377","https://openalex.org/W2163032035","https://openalex.org/W2169852145","https://openalex.org/W2586617343","https://openalex.org/W4233561050","https://openalex.org/W4242028206","https://openalex.org/W4248269869","https://openalex.org/W4249483860"],"related_works":["https://openalex.org/W2046969318","https://openalex.org/W4224219431","https://openalex.org/W2055637177","https://openalex.org/W2594240753","https://openalex.org/W4296623163","https://openalex.org/W4242880987","https://openalex.org/W3081816737","https://openalex.org/W2793004457","https://openalex.org/W2050543352","https://openalex.org/W3003946114"],"abstract_inverted_index":{"The":[0,49,86],"population":[1,50],"pharmacokinetics":[2],"of":[3,37,63,95,129,131,139],"ustekinumab":[4,38],"are":[5,31,74,97,119],"characterized":[6],"in":[7,15,106],"patients":[8,30],"with":[9,150],"moderate":[10],"to":[11,33,40,46,117,146],"severe":[12],"plaque":[13],"psoriasis":[14],"2":[16],"Phase":[17],"3":[18],"studies":[19],"(PHOENIX":[20],"1":[21],"and":[22,39,65,81,92,99,112,153],"PHOENIX":[23],"2).":[24],"Serum":[25],"concentration":[26],"data":[27],"from":[28,69],"1937":[29],"analyzed":[32],"determine":[34],"pharmacokinetic":[35],"characteristics":[36],"assess":[41],"factors":[42,104],"that":[43],"may":[44],"contribute":[45],"their":[47],"variability.":[48],"typical":[51],"mean":[52],"(percentage":[53],"relative":[54],"standard":[55],"error)":[56],"values":[57],"for":[58,89],"apparent":[59,61,90,93,124,127],"clearance,":[60],"volume":[62,94,128],"distribution,":[64],"absorption":[66],"rate":[67],"constant":[68],"the":[70,103,123,136,142,151],"final":[71],"covariate":[72,143],"model":[73],"0.465":[75],"L.day(-1)":[76],"(2.0%),":[77,80],"15.7":[78],"L":[79],"0.354":[82],"day(-1)":[83],"(16.2%),":[84],"respectively.":[85,101],"interindividual":[87],"variabilities":[88],"clearance":[91,125],"distribution":[96,130],"41.0%":[98],"33.2%,":[100],"Of":[102],"evaluated":[105,148],"this":[107],"analysis,":[108],"body":[109],"weight,":[110],"diabetes,":[111],"positive":[113],"immune":[114],"response":[115],"(antibodies":[116],"ustekinumab)":[118],"important":[120],"covariates":[121],"affecting":[122],"and/or":[126],"ustekinumab.":[132],"To":[133],"fully":[134],"understand":[135],"clinical":[137],"relevance":[138],"these":[140],"results,":[141],"findings":[144],"need":[145],"be":[147],"concurrently":[149],"efficacy":[152],"safety":[154],"data.":[155]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2006673542","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":16},{"year":2019,"cited_by_count":14},{"year":2018,"cited_by_count":13},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":16},{"year":2013,"cited_by_count":14},{"year":2012,"cited_by_count":11}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
